MD News - Advances in Prostate Cancer Treatment
Links shared publicly online about this topic.
- 653total visits
MD News - Advances in Prostate Cancer Treatment
View full resource at mdnews.com
Tags: Cancer, Prostate Cancer, Prostate, Men's Health, Urology, News
Most Recently Shared on December 15, 2010 at 5:48 pm By:
Advances in Prostate Cancer Treatment http://bit.ly/glNLNr
Research and Markets: Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010 - Yahoo! News
news.yahoo.com — “From Yahoo! News: Dublin - Research and Markets (http://www.researchandmarkets.com/research/4a4ba696/prostate_cancer) has announced the addition of GlobalData's new report "Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010" to their offering.” View full resource at news.yahoo.com
Most Recently Shared on March 29, 2012 at 11:29 am By:
Research and Markets: Prostate Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010: Dublin -... http://t.co/NBrxcovX
Prostate Cancer Therapy Too Good to Be True Explodes Health Cost - Bloomberg
bloomberg.com — “Imagine a prostate cancer therapy that has almost no side effects. Hospitals say it exists and they’re vying to be among the first to offer it. Too bad the treatment may not work as well as advertised and could boost America’s already spiraling health-care costs.” View full resource at bloomberg.com
Most Recently Shared on March 26, 2012 at 12:27 pm By:
The ASCO Post Oncology, Health Magazine, and Hematology
#ProstateCancer Therapy Too Good to Be True Explodes #HealthCareCosts http://t.co/SQbc6mbO (via Bloomberg) #protons #radiotherapy
One size does not fit all for prostate cancer treatment | Yale Daily News
yaledailynews.com — “Some men with prostate cancer may be getting too much treatment, according to Yale School of Medicine researchers.” View full resource at yaledailynews.com
Most Recently Shared on March 20, 2012 at 8:17 am By:
One size does not fit all for prostate cancer treatment: Some men with prostate cancer may be getting too much t... http://t.co/RiV3a2sh
Urology News - Intensity Modulated Radiation Therapy Replaces 3-Dimensional Conformal Radiotherapy as Prostate Cancer Treatment |3983991
mdlinx.com — “Urology Medical Article: Intensity Modulated Radiation Therapy Replaces 3-Dimensional Conformal Radiotherapy as Prostate Cancer Treatment” View full resource at mdlinx.com
Most Recently Shared on March 19, 2012 at 12:29 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Intensity Modulated Radiation Therapy Replaces 3-Dimensional Conformal Radiotherapy as Prostate Cancer ... http://t.co/gLueqXFo #urology
Have you ever prescribed sipuleucel-T for a prostate cancer patient? - Renal and Urology News
renalandurologynews.com — “Nearly two years have passed since the FDA approved sipuleucel-T—a therapeutic cancer vaccine developed and marketed by Dendreon Corp.” View full resource at renalandurologynews.com
Most Recently Shared on March 17, 2012 at 4:02 pm By:
Renal Urology News Nephrology, Urology, Medical Publisher, and Health News
Have you ever prescribed Provenge for prostate cancer treatment? http://t.co/aOUCzvUG #HCsm
Urology News - Vacuum Erection Devices Revisited: Its Emerging Role in the Treatment of Erectile Dysfunction and Early Penile Rehabilitation Following Prostate Cancer Therapy |3967820
mdlinx.com — “Urology Medical Article: Vacuum Erection Devices Revisited: Its Emerging Role in the Treatment of Erectile Dysfunction and Early Penile Rehabilitation Following Prostate Cancer Therapy” View full resource at mdlinx.com
Most Recently Shared on March 16, 2012 at 8:00 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Vacuum Erection Devices Revisited: Its Emerging Role in the Treatment of Erectile Dysfunction and Early... http://t.co/GPxkiKoJ #urology
MDxHealth fourth quarter total revenues increase 48% to €0.9M
news-medical.net — “MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced results for Q4 and full year 2011.” View full resource at news-medical.net
Most Recently Shared on March 15, 2012 at 12:06 pm By:
Prostate Cancer: MDxHealth fourth quarter total revenues increase 48% to €0.9M: MDxHealth SA, a leading molecula... http://t.co/V5r27Hld
Modified Citrus Pectin binds and blocks harmful effects of Galectin-3
news-medical.net — “Galectin-3 sounds like a planet out of "Star Trek," but it can be much more ominous. Recently, distinguished integrative physician Isaac Eliaz, M.D., presented breakthrough research demonstrating that the protein Galectin-3 is an active biomarker for numerous life-threatening diseases. Even more importantly, Dr. Eliaz showed how Modified Citrus Pectin (MCP) binds and blocks Galectin-3 throughout the body.” View full resource at news-medical.net
Most Recently Shared on March 14, 2012 at 8:22 am By:
Prostate Cancer: Modified Citrus Pectin binds and blocks harmful effects of Galectin-3: Galectin-3 sounds like a... http://t.co/L1z1i4eq
Older prostate cancer patients might be overtreated - WPFO FOX 23 | Maine, Local, News, Entertainment, ME
myfoxmaine.com — “MyFOXMaine is the online home of WPFO FOX23, which delivers FOX programming such as NFL, Major League Baseball, NASCAR, and American Idol. Local programming includes News13 on FOX and Good Day Maine.” View full resource at myfoxmaine.com
Most Recently Shared on March 1, 2012 at 3:59 pm By:
Older prostate cancer patients might be overtreated: Seniors may not benefit from prostate cancer treatment, acc... http://t.co/AKuua9bc
Tiltan initiates TL-118 Phase 2 clinical trial for pancreatic cancer
news-medical.net — “Tiltan Pharma Ltd. today announced that it has commenced a Phase 2 clinical trial of its anti-angiogenic product TL-118 for the treatment of pancreatic cancer.” View full resource at news-medical.net
Most Recently Shared on February 13, 2012 at 4:10 pm By:
Prostate Cancer: Tiltan initiates TL-118 Phase 2 clinical trial for pancreatic cancer: Tiltan Pharma Ltd. today ... http://t.co/91quBbZd
Drug May Slow Early Prostate Cancer: Study
health.yahoo.net — “TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avodart, a drug used to treat an enlarged prostate gland, may help slow the progression of early stage prostate cancer, reducing the need for aggressive treatment in some men.” View full resource at health.yahoo.net
Most Recently Shared on January 25, 2012 at 6:18 am By:
Jennifer Ann Grisso Nurse and Active Health Library
Drug May Slow Early Prostate Cancer: Study: TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avod... http://t.co/jUM5eixT
Drug May Slow Early Prostate Cancer: Study - Yahoo! News
news.yahoo.com — “From Yahoo! News: TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avodart, a drug used to treat an enlarged prostate gland, may help slow the progression of early stage prostate cancer, reducing the need for aggressive treatment in some men.” View full resource at news.yahoo.com
Most Recently Shared on January 24, 2012 at 2:42 pm By:
john clay mchugh Physician, Doctor, Surgeon, and Urologist
Drug May Slow Early Prostate Cancer: Study: TUESDAY, Jan. 24 (HealthDay News) -- New research suggests that Avod... http://t.co/cLzxFqhL
Proton Therapy Effective Prostate Cancer Treatment
medicalnewstoday.com — “Proton therapy, a type of external beam radiation therapy, is a safe and effective treatment for prostate cancer, according to two new studies published in the January issue of the International” View full resource at medicalnewstoday.com
Most Recently Shared on January 8, 2012 at 8:05 am By:
Proton Therapy Effective Prostate Cancer Treatment http://t.co/5fymVslB #prostate
UC HealthNews : Prostate Cancer Test Still Holds Value: UC Health Urologist Addresses Common Myths About the Disease
healthnews.uc.edu — “UC Health urologist Nilesh Patil, MD, addresses some of the common myths about prostate cancer and reinforces the importance of early detection through screening.” View full resource at healthnews.uc.edu
Most Recently Shared on January 6, 2012 at 9:41 pm By:
RT @nytimeshealth: #PSA Test Does Not Save Lives http://t.co/sY7jKiUG UC docs say this may cause unnecessary deaths. http://t.co/YIx5vKPm
Viamet commences VT-464 Phase 1/2 trial in castration-refractory prostate cancer
news-medical.net — “Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1/2 clinical trial of VT-464, an oral, potent and lyase-selective CYP17 inhibitor for the treatment of castration-refractory prostate cancer.” View full resource at news-medical.net
Most Recently Shared on January 5, 2012 at 10:28 am By:
News-Medical.Net Oncology and Health News
Oncology News: Viamet commences VT-464 Phase 1/2 trial in castration-refractory prostate cancer: Viamet Pharmace... http://t.co/WMSmelso
Advertisement
